Skip to the page

Data / Drug companies / Alembic Pharmaceuticals Inc.

Alembic Pharmaceuticals Inc.: 499 products in the FDA NDC directory, labeler code 62332

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Alembic Pharmaceuticals Inc. (labeler code 62332) lists 499 products in the FDA National Drug Code Directory, covering 175 finished drugs by generic name. By type: 495 prescription drugs, 4 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on November 2, 2026.

The request: Watch Alembic Pharmaceuticals Inc. (FDA labeler code 62332): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
62332
Products in commercial distribution
499
Packages
1,334
Finished drugs by generic name
175
Prescription products
495
Over the counter products
4
Controlled substance products
Schedule III 2, Schedule IV 15, Schedule V 12
Flagged as original packager
459 of 459 products that carry the flag
Started marketing in the last 12 months
51
Earliest marketing start
February 18, 2010
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)49899.8%
New drug applications (NDA)10.2%

Products by type

TypeProductsShare
Prescription drugs49599.2%
Over the counter drugs40.8%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Lamotrigine1351
Pramipexole dihydrochloride1223
Ropinirole1220
Diltiazem hydrochloride1255
Amlodipine and atorvastatin119
Doxycycline hyclate1161
Fenofibrate1156
Pregabalin854
Aripiprazole849
Deferasirox621
Carbidopa, levodopa and entacapone64
Desipramine hydrochloride68
Clobetasol propionate640
Dasatinib618
Fluoxetine542
Valsartan and hydrochlorothiazide521
Clonazepam536
Doxepin hydrochloride545
Venlafaxine533
Chlorpromazine53
Rivaroxaban524
Lurasidone hydrochloride528
Lithium carbonate424
Metronidazole468
Candesartan cilexetil48
Rivastigmine tartrate411
Celecoxib463
Lacosamide457
Tadalafil454
Amlodipine besylate and olmesartran medoxomil42
Vardenafil hydrochloride410
Temazepam428
Glycopyrrolate464
Paliperidone419
Clonidine hydrochloride445
Guanfacine433
Valsartan438
Amlodipine and valsartan410
Carbamazepine452
Olopatadine hydrochloride435
Zolmitriptan422
Treprostinil46
Fluphenazine hydrochloride429
Telmisartan and amlodipine44
Losartan potassium343
Irbesartan and hydrochlorothiazide315
Telmisartan and hydrochlorothiazide39
Cyclobenzaprine hydrochloride361
Doxycycline363
Triamcinolone acetonide377
Irbesartan327
Telmisartan329
Metoprolol312
Olmesartan medoxomil331
Vilazodone hydrochloride313
Azithromycin341
Desonide315
Sacubitril and valsartan329
Erlotinib hydrochloride34
Ketorolac tromethamine369
Paclitaxel320
Methotrexate331
Nifedipine338
Acitretin38
Paroxetine333
Metoprolol tartrate and hydrochlorothiazide35
Duloxetine336
Metolazone322
Dabigatran etexilate317
Asenapine34
Midodrine hydrochloride334
Tizanidine hydrochloride325
Prazosin hydrochloride335
Tretinoin328
Olmesartan medoxomil and hydrochlorothiazide317
Nitrofurantoin328
Venlafaxine hydrochloride348
Losartan potassium and hydrochlorothiazide331
Nadolol317
Clomipramine hydrochloride317
Oseltamivir35
Meprobamate23
Leflunomide219
Darifenacin27
Carbidopa and levodopa241
Silodosin215
Ticagrelor232
Bimatoprost215
Chlorthalidone242
Prucalopride218
Fesoterodine fumarate212
Pirfenidone226
Dexlansoprazole212
Famotidine2138
Bupropion hydrochloride267
Febuxostat222
Testosterone222
Memantine hydrochloride236
Fenofibric acid27
Bosutinib25

Dosage forms

Dosage formProductsShare
Tablet, film coated14529.1%
Tablet8817.6%
Capsule7014%
Tablet, extended release306%
Solution/ drops234.6%
Injection163.2%
Tablet, orally disintegrating142.8%
Tablet, coated132.6%
Capsule, extended release132.6%
Injection, solution112.2%
Tablet, film coated, extended release112.2%
Cream102%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Ciprofloxacin otic62332-168Solution/ dropsGeneric drugs (ANDA)November 2, 2026
Valganciclovir62332-754Powder, for solutionGeneric drugs (ANDA)October 28, 2026
Ciprofloxacin and Dexamethasone62332-776Suspension/ dropsGeneric drugs (ANDA)October 15, 2026
Clonidine hydrochloride62332-169TabletGeneric drugs (ANDA)September 22, 2026
Prucalopride62332-078Tablet, film coatedGeneric drugs (ANDA)July 31, 2026
Prucalopride62332-077Tablet, film coatedGeneric drugs (ANDA)July 31, 2026
Dapsone62332-551GelGeneric drugs (ANDA)July 1, 2026
Oseltamivir phosphate62332-769For suspensionGeneric drugs (ANDA)June 29, 2026
Tretinoin62332-808CreamGeneric drugs (ANDA)June 11, 2026
Macitentan62332-373Tablet, film coatedGeneric drugs (ANDA)June 6, 2026
Bosutinib62332-312Tablet, film coatedGeneric drugs (ANDA)May 19, 2026
Bosutinib62332-311Tablet, film coatedGeneric drugs (ANDA)May 19, 2026
Fingolimod62332-228CapsuleGeneric drugs (ANDA)April 28, 2026
Methotrexate62332-712Injection, solutionGeneric drugs (ANDA)April 15, 2026
Methotrexate62332-711Injection, solutionGeneric drugs (ANDA)April 15, 2026
Duloxetine hydrochloride62332-280Capsule, delayed releaseGeneric drugs (ANDA)April 9, 2026
Duloxetine hydrochloride62332-279Capsule, delayed releaseGeneric drugs (ANDA)April 9, 2026
Duloxetine hydrochloride62332-278Capsule, delayed releaseGeneric drugs (ANDA)April 9, 2026
Dapagliflozin62332-393Tablet, film coatedGeneric drugs (ANDA)April 6, 2026
Dapagliflozin62332-392Tablet, film coatedGeneric drugs (ANDA)April 6, 2026
Paroxetine62332-766Tablet, film coated, extended releaseGeneric drugs (ANDA)March 31, 2026
Telmisartan and Amlodipine62332-187TabletGeneric drugs (ANDA)March 31, 2026
Telmisartan and Amlodipine62332-186TabletGeneric drugs (ANDA)March 31, 2026
Telmisartan and Amlodipine62332-185TabletGeneric drugs (ANDA)March 31, 2026
Telmisartan and Amlodipine62332-184TabletGeneric drugs (ANDA)March 31, 2026

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.